Sector revisions DaShenLin Pharmaceutical Group Co., Ltd.

Equities

End-of-day quote Shanghai S.E. Other stock markets 12/02/2026			5-day change	1st Jan Change
19.50 ^CNY	+0.57%		-1.91%	+10.67%

29/10/25	DaShenLin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025	CI
28/08/25	DaShenLin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2025	CI

Add to a list 0 selected To use this feature you must be a member Log in Sign up	4m. EPS revision	1y. EPS revision	Visibility	Nbr of analysts
DASHENLIN PHARMACEUTICAL GROUP CO., LTD.				8
JD HEALTH INTERNATIONAL INC.				16
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED				16
MATSUKIYOCOCOKARA & CO.				10
CLICKS GROUP LIMITED				9
YIFENG PHARMACY CHAIN CO., LTD.				12
NAHDI MEDICAL COMPANY				8
CORPORATIVO FRAGUA, S.A.B. DE C.V.	-	-	-	1
GUARDIAN PHARMACY SERVICES, INC.				4
DIS-CHEM PHARMACIES LIMITED				8
REDCARE PHARMACY NV				9
MEDPLUS HEALTH SERVICES LIMITED				7
YIXINTANG PHARMACEUTICAL GROUP CO., LTD.				4
AL-DAWAA MEDICAL SERVICES COMPANY				7
GENKY DRUGSTORES CO., LTD.				2
EMPREENDIMENTOS PAGUE MENOS S.A.				7
APOTEA AB			-	1
Average				8
Weighted average by Cap.				12